Alexander G Panossian (Alexander Panossian)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Respiratory Syndrome Coronavirus

Helicobacter Pylori

Immune Response

Top Venues

Pharmaceuticals (Basel, Switzerland)

Medicinal research reviews

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander G Panossian, Terry Lemerond, Thomas Efferth
State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Alexander G Panossian, Terry Lemerond, Thomas Efferth
State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Levan Ratiani, Elene Pachkoria, Nato Mamageishvili, Ramaz Shengelia, Areg Hovhannisyan, Alexander G Panossian
Efficacy of Kan Jang ® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Levan Ratiani, Elene Pachkoria, Nato Mamageishvili, Ramaz Shengelia, Areg Hovhannisyan, Alexander G Panossian
Efficacy of Kan Jang ® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Irina Karosanidze, Ushangi Kiladze, Nino Kirtadze, Mikhail Giorgadze, Nana Amashukeli, Nino Parulava, Neli Iluridze, Nana Kikabidze, Nana Gudavadze, Lali Gelashvili, Vazha Koberidze, Eka Gigashvili, Natela Jajanidze, Naira Latsabidze, Nato Mamageishvili, Ramaz Shengelia, Areg Hovhannisyan, Alexander G Panossian
Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Alexander G Panossian, Thomas Efferth
Network Pharmacology of Adaptogens in the Assessment of Their Pleiotropic Therapeutic Activity. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Alexander G Panossian, Sara Abdalfattah, Thomas Efferth
Network Pharmacology of Ginseng (Part III): Antitumor Potential of a Fixed Combination of Red Ginseng and Red Sage as Determined by Transcriptomics. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Wilfried Dimpfel, Pierre-Antoine Mariage, Alexander G Panossian
Effects of Red and White Ginseng Preparations on Electrical Activity of the Brain in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled, Three-Armed Cross-Over Study. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Alexander G Panossian, Sara Abdalfattah, Thomas Efferth
Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Alexander G Panossian, Sara Abdalfattah, Thomas Efferth
Network Pharmacology of Ginseng (Part II): The Differential Effects of Red Ginseng and Ginsenoside Rg5 in Cancer and Heart Diseases as Determined by Transcriptomics. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Alexander G Panossian, Thomas Brendler
The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Thomas Brendler, Ahmed Al Harrasi, Rudolf Bauer, Stefan Gafner, Mary L Hardy, Michael Heinrich, Mahboobeh Ghasemzadeh Rahbardar, Angelo A Izzo, Martin Michaelis, Marjan Nassiri-Asl, Alexander G Panossian, Solomon P Wasser, Elizabeth Mary Williamson
Botanical drugs and supplements affecting the immune response in the time of COVID-19: Implications for research and clinical practice. Phytotherapy research : PTR 35 (6) (2020)
Alexander G Panossian, Thomas Efferth, Alexander N Shikov, Olga N Pozharitskaya, Kenny Kuchta, Pulok K Mukherjee, Subhadip Banerjee, Michael Heinrich, Wanying Wu, De-An Guo, Hildebert Wagner
Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Medicinal research reviews 41 (1) (2020)